CRL-2876 VCaP 人前列腺癌細(xì)胞

]資料

點(diǎn)擊看大圖

如果您對(duì)該產(chǎn)品感興趣的話,可以

產(chǎn)品名稱: CRL-2876 VCaP 人前列腺癌細(xì)胞
產(chǎn)品型號(hào): CRL-2876 VCaP
產(chǎn)品廠商: 美國(guó)標(biāo)準(zhǔn)生物品收藏中心（ATCC）
產(chǎn)品文檔: 無(wú)相關(guān)文檔

簡(jiǎn)單介紹

CRL-2876 VCaP 人前列腺癌細(xì)胞 ATCC 細(xì)胞|細(xì)胞系|細(xì)胞株|腫瘤細(xì)胞|細(xì)胞；細(xì)胞庫(kù)管理規(guī)范，提供的細(xì)胞株背景清楚，提供參考文獻(xiàn)和培養(yǎng)條件！

CRL-2876 VCaP 人前列腺癌細(xì)胞的詳細(xì)介紹

CRL-2876 VCaP 人前列腺癌細(xì)胞

Designations:	VCaP
Depositors:	KJ Pienta
Biosafety Level:	2 [(cells produce the mouse xenotropic retrovirus Bxv-1) ]
Shipped:	frozen
Medium & Serum:	See Propagation
Growth Properties:	adherent
Organism:	Homo sapiens

Source:	Organ: prostate Tissue: vertebral metastasis Disease: cancer Cell Type: epithelial
Permits/Forms:	In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.

Isolation:	Isolation date: 1997
Applications:	This line was established in 1997 from a vertebral bone metastasis from a patient with hormone refractory prostate cancer.
Tumorigenic:	Yes
Antigen Expression:	cytokeratin-18; Homo sapiens, expressed p53 antigen; Homo sapiens, expressed prostate specific antigen (PSA); Homo sapiens, expressed prostatic acid phosphatase (PAP); Homo sapiens, expressed Rb protein; Homo sapiens, expressed
DNA Profile (STR):	Amelogenin: X,Y CSF1PO: 10,12 D13S317: 11,12 D16S539: 9 D5S818: 12 D7S820: 9,12 THO1: 9.3 TPOX: 8,11 vWA: 18,19
Age:	59 years
Gender:	male
Ethnicity:	Caucasian
Comments:	This line was established in 1997 from a vertebral bone metastasis from a patient with hormone refractory prostate cancer. It was passaged as xenografts in mice then cultured in vitro. It is androgen sensitive in vitro and in vivo. Recently, it has been shown that VCaP prostate cancer cells produce the mouse xenotropic retrovirus Bxv-1, which was likely acquired by the cells during their xenotransplantation in mice.
Propagation:	ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%. Atmosphere: air, 95%; carbon dioxide (CO2), 5% Temperature: 37.0°C
Subculturing:	Protocol: Remove and discard culture medium. Briefly rinse the cell layer with Hank's Balanced Salt Solution or 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor. Add 1.0 to 2.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes). Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal. Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting. Add appropriate aliquots of the cell suspension to new culture vessels. An inoculum of 2 X 10(4) to 4 X 10(4) viable cells/sq. cm is recommended. Incubate cultures at 37°C. Interval: Subculture when the cell concentration reaches between 1 X 10(5) and 2 X 10(5) cells/sq. cm. Subcultivation Ratio: 1:3 to 1:4
Preservation:	Freeze medium: 95% growth medium; 5% DMSO Storage temperature: liquid nitrogen vapor phase
Doubling Time:	about 53 hours
Related Products:	Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2002 recommended serum:ATCC 30-2020 0.25% (w/v) Trypsin - 0.53 mM EDTA in Hank' BSS (w/o Ca++, Mg++):ATCC 30-2101 Cell culture tested DMSO:ATCC 4-X Erythrosin B vital stain solution:ATCC 30-2404 Trypan Blue vital stain solution:ATCC 30-2402
References:	92253: Korenchuk S, et al. VCaP, a cell-based model system of human prostate cancer. In Vivo 15: 163-168, 2001. PubMed: 11317522 16173979: Knouf EC, et al. Multiple Integrated Copies and High-Level Production of the Human Retrovirus XMRV from 22Rv1 Prostate Carcinoma Cells. J. Virol. 83: 7353-7356, 2009. PubMed: 19403664 16173980: Sfanos KS, et al. Identification of replication competent murine gamma retroviruses in commonly used prostate cancer cell lines. PLoS One 6:e20874, 2011.

產(chǎn)品留言

標(biāo)題

聯(lián)系人

聯(lián)系電話

內(nèi)容

驗(yàn)證碼

點(diǎn)擊換一張

注：1.可以使用快捷鍵Alt+S或Ctrl+Enter發(fā)送信息!
2.如有必要,請(qǐng)您留下您的詳細(xì)聯(lián)系方式!

相關(guān)產(chǎn)品

3T3D 人骨髓瘤細(xì)胞 3T3D 人骨髓瘤細(xì)胞

HTB-120 NCI-H128 人肺小細(xì)胞肺癌細(xì)胞 HTB 120 NCI H128

HTB-119 NCI-H69 [H69]人肺小細(xì)胞肺癌細(xì)胞 HTB-119

HS77 人肺小細(xì)胞肺癌細(xì)胞 HS77

D6 人肺腺癌細(xì)胞 D6

聯(lián)系我們



 	電      話：021-35080510

 手       機(jī): 15000266580（微信同步）

 菌種Q Q ： 316826860

 細(xì)胞Q Q ：1784382136

  
 

 
 	菌種Q Q:1623059823 
 
 Email：xiangfbio@163.com

產(chǎn)品搜索

細(xì)胞系，ATCC細(xì)胞，ATCC菌種，細(xì)胞系目錄，ATCC，鼠傷寒沙門氏菌，atcc細(xì)胞庫(kù)，人**瘤細(xì)胞，人食管癌細(xì)胞，ATCC 19404，ATCC 25922，ATCC 19146，微生物菌種，細(xì)胞株，標(biāo)準(zhǔn)菌株，ATCC中國(guó)，atcc上海代理，CMCC 菌株，ATCC菌株，細(xì)胞目錄，質(zhì)控菌株，腫瘤細(xì)胞株，乳腺癌細(xì)胞系，人肝癌細(xì)胞系

產(chǎn)品目錄

Copyright? 2003-2025 上海復(fù)祥生物科技有限公司版權(quán)所有電話：021-35080510
傳真：021-35080520 地址：上海市虹口區(qū)赤峰路630號(hào)南雁大廈1901室郵編：滬ICP備10013034號(hào)-3

CRL-2876 VCaP 人前列腺癌細(xì)胞

CRL-2876 VCaP 人前列腺癌細(xì)胞 ATCC 細(xì)胞|細(xì)胞系|細(xì)胞株|腫瘤細(xì)胞|細(xì)胞；細(xì)胞庫(kù)管理規(guī)范，提供的細(xì)胞株背景清楚，提供參考文獻(xiàn)和培養(yǎng)條件！

CRL-2876 VCaP 人前列腺癌細(xì)胞 ATCC 細(xì)胞|細(xì)胞系|細(xì)胞株|腫瘤細(xì)胞|細(xì)胞；細(xì)胞庫(kù)管理規(guī)范，提供的細(xì)胞株背景清楚，提供參考文獻(xiàn)和培養(yǎng)條件！